ACTL6A and head and neck squamous cell carcinoma: Modifying ACTL6A expression had significant effects on mitochondrial dependency in HNSCC cells, with low levels of ACTL6A abrogating hypoxic cell growth as well as sensitizing cells to cytotoxicity using the oxidative phosphorylation inhibitor IACS-010759.